Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...
GoodRx helps consumers find lower prescription prices via a platform that compares costs across pharmacies. The company's revenue includes fees from pharmacies and PBMs, plus earnings from advertising ...
Hosted on MSN
GoodRx price target lowered to $3 from $3.40 at BofA
BofA lowered the firm’s price target on GoodRx (GDRX) to $3 from $3.40 and keeps an Underperform rating on the shares after the company announced two initiatives for its weight loss offering. BofA ...
neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRx neffy is the first and only needle-free treatment for Type I ...
SAN FRANCISCO — Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. The health information network announced Tuesday at the J.P. Morgan Healthcare Conference ...
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx ...
Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transform the medication experience and empower patients by bringing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results